FDA Inspection
Jubilant Generics LimitedJubilant Generics Limited – FDA Inspection, Mar 12, 2021
Record Details
This FDA Inspection record concerns Jubilant Generics Limited, with an inspection on March 12, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Jubilant Generics Limited
- Inspection Date
- March 12, 2021
- Product Type
- Drugs
View Company Profile
ID · fc2e71ae-4a8d-48c0-be12-652a7f9d3a86
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1137148
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Jubilant Generics Limited
9| Date | Classification | Office | Project area |
|---|---|---|---|
| August 1, 2025 | OAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| February 2, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 1, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 8, 2018 | Not classified | Office of Inspections and Investigations | Generic Drug Evaluation |
Other documents for Jubilant Generics Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.